当前位置:
X-MOL 学术
›
Cancer Cell
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
A Microbiota-Derived Metabolite Augments Cancer Immunotherapy Responses in Mice
Cancer Cell ( IF 48.8 ) Pub Date : 2020-09-24 , DOI: 10.1016/j.ccell.2020.09.005 Emma Allen-Vercoe , Bryan Coburn
中文翻译:
微生物衍生的代谢产物增强了小鼠的癌症免疫治疗反应。
更新日期:2020-10-13
Cancer Cell ( IF 48.8 ) Pub Date : 2020-09-24 , DOI: 10.1016/j.ccell.2020.09.005 Emma Allen-Vercoe , Bryan Coburn
Improving the rate of patient response to immune checkpoint blockade therapy is a current clinical goal. An article published in Science suggests that some members of the gut microbiome may provide a key molecule toward this end.
中文翻译:
微生物衍生的代谢产物增强了小鼠的癌症免疫治疗反应。
提高患者对免疫检查点封锁疗法的反应率是当前的临床目标。在《科学》杂志上发表的一篇文章表明,肠道微生物组的某些成员可能为此提供了关键分子。